 | • レポートコード：GIR-105X13119 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、店頭（OTC）薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。店頭（OTC）薬の種類別市場規模（鎮痛剤、皮膚科製品、胃腸製品、ビタミン、ミネラル、サプリメント（VMS）、減量/ダイエット製品、眼科製品、睡眠薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・店頭（OTC）薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bayer AG、Boehringer Ingelheim、GlaxoSmithKline PLC、Johnson & Johnson、Novartis International AG、Pfizer,Inc.、PGT healthcare、Sanofi S.A、Takeda ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：鎮痛剤、皮膚科製品、胃腸製品、ビタミン、ミネラル、サプリメント（VMS）、減量/ダイエット製品、眼科製品、睡眠薬、その他 ・用途別分析2016年-2026年：病院薬局、小売薬局、オンライン薬局、その他 ・店頭（OTC）薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・店頭（OTC）薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・店頭（OTC）薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・店頭（OTC）薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・店頭（OTC）薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Over The Counter (OTC) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Over The Counter (OTC) Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Over The Counter (OTC) Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Over The Counter (OTC) Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Analgesics
Dermatology Products
Gastrointestinal Products
Vitamins, Mineral, and Supplements (VMS)
Weight Loss/Dietary Products
Ophthalmic Products
Sleeping Aids
Others
Market segment by Application can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacy
Others
The key market players for global Over The Counter (OTC) Drugs market are listed below:
Bayer AG
Boehringer Ingelheim
GlaxoSmithKline PLC
Johnson & Johnson
Novartis International AG
Pfizer,Inc.
PGT healthcare
Sanofi S.A
Takeda
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Over The Counter (OTC) Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Over The Counter (OTC) Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Analgesics
1.2.3 Dermatology Products
1.2.4 Gastrointestinal Products
1.2.5 Vitamins, Mineral, and Supplements (VMS)
1.2.6 Weight Loss/Dietary Products
1.2.7 Ophthalmic Products
1.2.8 Sleeping Aids
1.2.9 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Over The Counter (OTC) Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Global Over The Counter (OTC) Drugs Market Size & Forecast
1.4.1 Global Over The Counter (OTC) Drugs Sales in Value (2016-2026))
1.4.2 Global Over The Counter (OTC) Drugs Sales in Volume (2016-2026)
1.4.3 Global Over The Counter (OTC) Drugs Price by Type (2016-2026) & (USD/MT)
1.5 Global Over The Counter (OTC) Drugs Production Capacity Analysis
1.5.1 Global Over The Counter (OTC) Drugs Total Production Capacity (2016-2026)
1.5.2 Global Over The Counter (OTC) Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Over The Counter (OTC) Drugs Market Drivers
1.6.2 Over The Counter (OTC) Drugs Market Restraints
1.6.3 Over The Counter (OTC) Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Bayer AG
2.1.1 Bayer AG Details
2.1.2 Bayer AG Major Business
2.1.3 Bayer AG Over The Counter (OTC) Drugs Product and Services
2.1.4 Bayer AG Over The Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business
2.2.3 Boehringer Ingelheim Over The Counter (OTC) Drugs Product and Services
2.2.4 Boehringer Ingelheim Over The Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 GlaxoSmithKline PLC
2.3.1 GlaxoSmithKline PLC Details
2.3.2 GlaxoSmithKline PLC Major Business
2.3.3 GlaxoSmithKline PLC Over The Counter (OTC) Drugs Product and Services
2.3.4 GlaxoSmithKline PLC Over The Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Over The Counter (OTC) Drugs Product and Services
2.4.4 Johnson & Johnson Over The Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Novartis International AG
2.5.1 Novartis International AG Details
2.5.2 Novartis International AG Major Business
2.5.3 Novartis International AG Over The Counter (OTC) Drugs Product and Services
2.5.4 Novartis International AG Over The Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Pfizer,Inc.
2.6.1 Pfizer,Inc. Details
2.6.2 Pfizer,Inc. Major Business
2.6.3 Pfizer,Inc. Over The Counter (OTC) Drugs Product and Services
2.6.4 Pfizer,Inc. Over The Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 PGT healthcare
2.7.1 PGT healthcare Details
2.7.2 PGT healthcare Major Business
2.7.3 PGT healthcare Over The Counter (OTC) Drugs Product and Services
2.7.4 PGT healthcare Over The Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Sanofi S.A
2.8.1 Sanofi S.A Details
2.8.2 Sanofi S.A Major Business
2.8.3 Sanofi S.A Over The Counter (OTC) Drugs Product and Services
2.8.4 Sanofi S.A Over The Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Takeda
2.9.1 Takeda Details
2.9.2 Takeda Major Business
2.9.3 Takeda Over The Counter (OTC) Drugs Product and Services
2.9.4 Takeda Over The Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Over The Counter (OTC) Drugs Sales by Manufacturer
3.1 Global Over The Counter (OTC) Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Over The Counter (OTC) Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Over The Counter (OTC) Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Over The Counter (OTC) Drugs Manufacturer Market Share
3.4.2 Top 6 Over The Counter (OTC) Drugs Manufacturer Market Share
3.5 Global Over The Counter (OTC) Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Over The Counter (OTC) Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Over The Counter (OTC) Drugs Market Size by Region
4.1.1 Global Over The Counter (OTC) Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Over The Counter (OTC) Drugs Revenue by Region (2016-2026)
4.2 North America Over The Counter (OTC) Drugs Revenue (2016-2026)
4.3 Europe Over The Counter (OTC) Drugs Revenue (2016-2026)
4.4 Asia-Pacific Over The Counter (OTC) Drugs Revenue (2016-2026)
4.5 South America Over The Counter (OTC) Drugs Revenue (2016-2026)
4.6 Middle East and Africa Over The Counter (OTC) Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Over The Counter (OTC) Drugs Sales in Volume by Type (2016-2026)
5.2 Global Over The Counter (OTC) Drugs Revenue by Type (2016-2026)
5.3 Global Over The Counter (OTC) Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Over The Counter (OTC) Drugs Sales in Volume by Application (2016-2026)
6.2 Global Over The Counter (OTC) Drugs Revenue by Application (2016-2026)
6.3 Global Over The Counter (OTC) Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Over The Counter (OTC) Drugs Sales by Type (2016-2026)
7.2 North America Over The Counter (OTC) Drugs Sales by Application (2016-2026)
7.3 North America Over The Counter (OTC) Drugs Market Size by Country
7.3.1 North America Over The Counter (OTC) Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Over The Counter (OTC) Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Over The Counter (OTC) Drugs Sales by Type (2016-2026)
8.2 Europe Over The Counter (OTC) Drugs Sales by Application (2016-2026)
8.3 Europe Over The Counter (OTC) Drugs Market Size by Country
8.3.1 Europe Over The Counter (OTC) Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Over The Counter (OTC) Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Over The Counter (OTC) Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Over The Counter (OTC) Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Region
9.3.1 Asia-Pacific Over The Counter (OTC) Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Over The Counter (OTC) Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Over The Counter (OTC) Drugs Sales by Type (2016-2026)
10.2 South America Over The Counter (OTC) Drugs Sales by Application (2016-2026)
10.3 South America Over The Counter (OTC) Drugs Market Size by Country
10.3.1 South America Over The Counter (OTC) Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Over The Counter (OTC) Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Over The Counter (OTC) Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Over The Counter (OTC) Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Country
11.3.1 Middle East & Africa Over The Counter (OTC) Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Over The Counter (OTC) Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Over The Counter (OTC) Drugs Typical Distributors
12.3 Over The Counter (OTC) Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Over The Counter (OTC) Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Over The Counter (OTC) Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 4. Bayer AG Major Business
Table 5. Bayer AG Over The Counter (OTC) Drugs Product and Services
Table 6. Bayer AG Over The Counter (OTC) Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 8. Boehringer Ingelheim Major Business
Table 9. Boehringer Ingelheim Over The Counter (OTC) Drugs Product and Services
Table 10. Boehringer Ingelheim Over The Counter (OTC) Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. GlaxoSmithKline PLC Basic Information, Manufacturing Base and Competitors
Table 12. GlaxoSmithKline PLC Major Business
Table 13. GlaxoSmithKline PLC Over The Counter (OTC) Drugs Product and Services
Table 14. GlaxoSmithKline PLC Over The Counter (OTC) Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 16. Johnson & Johnson Major Business
Table 17. Johnson & Johnson Over The Counter (OTC) Drugs Product and Services
Table 18. Johnson & Johnson Over The Counter (OTC) Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Novartis International AG Basic Information, Manufacturing Base and Competitors
Table 20. Novartis International AG Major Business
Table 21. Novartis International AG Over The Counter (OTC) Drugs Product and Services
Table 22. Novartis International AG Over The Counter (OTC) Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Pfizer,Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer,Inc. Major Business
Table 25. Pfizer,Inc. Over The Counter (OTC) Drugs Product and Services
Table 26. Pfizer,Inc. Over The Counter (OTC) Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. PGT healthcare Basic Information, Manufacturing Base and Competitors
Table 28. PGT healthcare Major Business
Table 29. PGT healthcare Over The Counter (OTC) Drugs Product and Services
Table 30. PGT healthcare Over The Counter (OTC) Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Sanofi S.A Basic Information, Manufacturing Base and Competitors
Table 32. Sanofi S.A Major Business
Table 33. Sanofi S.A Over The Counter (OTC) Drugs Product and Services
Table 34. Sanofi S.A Over The Counter (OTC) Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Takeda Basic Information, Manufacturing Base and Competitors
Table 36. Takeda Major Business
Table 37. Takeda Over The Counter (OTC) Drugs Product and Services
Table 38. Takeda Over The Counter (OTC) Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Over The Counter (OTC) Drugs Sales by Manufacturer (2019-2021e) & (K MT)
Table 40. Global Over The Counter (OTC) Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Over The Counter (OTC) Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Over The Counter (OTC) Drugs Production Capacity by Company, (K MT): 2020 VS 2021
Table 43. Head Office and Over The Counter (OTC) Drugs Production Site of Key Manufacturer
Table 44. Global Over The Counter (OTC) Drugs Sales by Region (2016-2021e) & (K MT)
Table 45. Global Over The Counter (OTC) Drugs Sales by Region (2021-2026) & (K MT)
Table 46. Global Over The Counter (OTC) Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 47. Global Over The Counter (OTC) Drugs Revenue by Region (2021-2026) & (USD Million)
Table 48. Global Over The Counter (OTC) Drugs Sales by Type (2016-2021e) & (K MT)
Table 49. Global Over The Counter (OTC) Drugs Sales by Type (2021-2026) & (K MT)
Table 50. Global Over The Counter (OTC) Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 51. Global Over The Counter (OTC) Drugs Revenue by Type (2021-2026) & (USD Million)
Table 52. Global Over The Counter (OTC) Drugs Price by Type (2016-2021e) & (USD/MT)
Table 53. Global Over The Counter (OTC) Drugs Price by Type (2021-2026) & (USD/MT)
Table 54. Global Over The Counter (OTC) Drugs Sales by Application (2016-2021e) & (K MT)
Table 55. Global Over The Counter (OTC) Drugs Sales by Application (2021-2026) & (K MT)
Table 56. Global Over The Counter (OTC) Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 57. Global Over The Counter (OTC) Drugs Revenue by Application (2021-2026) & (USD Million)
Table 58. Global Over The Counter (OTC) Drugs Price by Application (2016-2021e) & (USD/MT)
Table 59. Global Over The Counter (OTC) Drugs Price by Application (2021-2026) & (USD/MT)
Table 60. North America Over The Counter (OTC) Drugs Sales by Country (2016-2021e) & (K MT)
Table 61. North America Over The Counter (OTC) Drugs Sales by Country (2021-2026) & (K MT)
Table 62. North America Over The Counter (OTC) Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 63. North America Over The Counter (OTC) Drugs Revenue by Country (2021-2026) & (USD Million)
Table 64. North America Over The Counter (OTC) Drugs Sales by Type (2016-2021e) & (K MT)
Table 65. North America Over The Counter (OTC) Drugs Sales by Type (2021-2026) & (K MT)
Table 66. North America Over The Counter (OTC) Drugs Sales by Application (2016-2021e) & (K MT)
Table 67. North America Over The Counter (OTC) Drugs Sales by Application (2021-2026) & (K MT)
Table 68. Europe Over The Counter (OTC) Drugs Sales by Country (2016-2021e) & (K MT)
Table 69. Europe Over The Counter (OTC) Drugs Sales by Country (2021-2026) & (K MT)
Table 70. Europe Over The Counter (OTC) Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 71. Europe Over The Counter (OTC) Drugs Revenue by Country (2021-2026) & (USD Million)
Table 72. Europe Over The Counter (OTC) Drugs Sales by Type (2016-2021e) & (K MT)
Table 73. Europe Over The Counter (OTC) Drugs Sales by Type (2021-2026) & (K MT)
Table 74. Europe Over The Counter (OTC) Drugs Sales by Application (2016-2021e) & (K MT)
Table 75. Europe Over The Counter (OTC) Drugs Sales by Application (2021-2026) & (K MT)
Table 76. Asia-Pacific Over The Counter (OTC) Drugs Sales by Region (2016-2021e) & (K MT)
Table 77. Asia-Pacific Over The Counter (OTC) Drugs Sales by Region (2021-2026) & (K MT)
Table 78. Asia-Pacific Over The Counter (OTC) Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 79. Asia-Pacific Over The Counter (OTC) Drugs Revenue by Region (2021-2026) & (USD Million)
Table 80. Asia-Pacific Over The Counter (OTC) Drugs Sales by Type (2016-2021e) & (K MT)
Table 81. Asia-Pacific Over The Counter (OTC) Drugs Sales by Type (2021-2026) & (K MT)
Table 82. Asia-Pacific Over The Counter (OTC) Drugs Sales by Application (2016-2021e) & (K MT)
Table 83. Asia-Pacific Over The Counter (OTC) Drugs Sales by Application (2021-2026) & (K MT)
Table 84. South America Over The Counter (OTC) Drugs Sales by Country (2016-2021e) & (K MT)
Table 85. South America Over The Counter (OTC) Drugs Sales by Country (2021-2026) & (K MT)
Table 86. South America Over The Counter (OTC) Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 87. South America Over The Counter (OTC) Drugs Revenue by Country (2021-2026) & (USD Million)
Table 88. South America Over The Counter (OTC) Drugs Sales by Type (2016-2021e) & (K MT)
Table 89. South America Over The Counter (OTC) Drugs Sales by Type (2021-2026) & (K MT)
Table 90. South America Over The Counter (OTC) Drugs Sales by Application (2016-2021e) & (K MT)
Table 91. South America Over The Counter (OTC) Drugs Sales by Application (2021-2026) & (K MT)
Table 92. Middle East & Africa Over The Counter (OTC) Drugs Sales by Country (2016-2021e) & (K MT)
Table 93. Middle East & Africa Over The Counter (OTC) Drugs Sales by Country (2021-2026) & (K MT)
Table 94. Middle East & Africa Over The Counter (OTC) Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 95. Middle East & Africa Over The Counter (OTC) Drugs Revenue by Country (2021-2026) & (USD Million)
Table 96. Middle East & Africa Over The Counter (OTC) Drugs Sales by Type (2016-2021e) & (K MT)
Table 97. Middle East & Africa Over The Counter (OTC) Drugs Sales by Type (2021-2026) & (K MT)
Table 98. Middle East & Africa Over The Counter (OTC) Drugs Sales by Application (2016-2021e) & (K MT)
Table 99. Middle East & Africa Over The Counter (OTC) Drugs Sales by Application (2021-2026) & (K MT)
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Over The Counter (OTC) Drugs Typical Distributors
Table 103. Over The Counter (OTC) Drugs Typical Customers
List of Figures
Figure 1. Over The Counter (OTC) Drugs Picture
Figure 2. Global Over The Counter (OTC) Drugs Sales Market Share by Type in 2020
Figure 3. Analgesics
Figure 4. Dermatology Products
Figure 5. Gastrointestinal Products
Figure 6. Vitamins, Mineral, and Supplements (VMS)
Figure 7. Weight Loss/Dietary Products
Figure 8. Ophthalmic Products
Figure 9. Sleeping Aids
Figure 10. Others
Figure 11. Global Over The Counter (OTC) Drugs Sales Market Share by Application in 2020
Figure 12. Hospital Pharmacies
Figure 13. Retail Pharmacies
Figure 14. Online Pharmacy
Figure 15. Others
Figure 16. Global Over The Counter (OTC) Drugs Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 17. Global Over The Counter (OTC) Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 18. United States Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Canada Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Mexico Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Germany Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. France Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. United Kingdom Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Russia Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Italy Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. China Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Japan Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Korea Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. India Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Southeast Asia Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Australia Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Brazil Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Egypt Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Saudi Arabia Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. South Africa Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 36. Turkey Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 37. Global Over The Counter (OTC) Drugs Sales (2016-2026) & (K MT)
Figure 38. Global Over The Counter (OTC) Drugs Production Capacity (2016-2026) & (K MT)
Figure 39. Global Over The Counter (OTC) Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 40. Over The Counter (OTC) Drugs Market Drivers
Figure 41. Over The Counter (OTC) Drugs Market Restraints
Figure 42. Over The Counter (OTC) Drugs Market Trends
Figure 43. Global Over The Counter (OTC) Drugs Sales Market Share by Manufacturer in 2020
Figure 44. Global Over The Counter (OTC) Drugs Revenue Market Share by Manufacturer in 2020
Figure 45. Over The Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 46. Top 3 Over The Counter (OTC) Drugs Manufacturer (Revenue) Market Share in 2020
Figure 47. Top 6 Over The Counter (OTC) Drugs Manufacturer (Revenue) Market Share in 2020
Figure 48. Global Over The Counter (OTC) Drugs Sales Market Share by Region (2016-2026)
Figure 49. Global Over The Counter (OTC) Drugs Revenue Market Share by Region (2016-2026)
Figure 50. North America Over The Counter (OTC) Drugs Revenue (2016-2026) & (USD Million)
Figure 51. Europe Over The Counter (OTC) Drugs Revenue (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Over The Counter (OTC) Drugs Revenue (2016-2026) & (USD Million)
Figure 53. South America Over The Counter (OTC) Drugs Revenue (2016-2026) & (USD Million)
Figure 54. Middle East & Africa Over The Counter (OTC) Drugs Revenue (2016-2026) & (USD Million)
Figure 55. Global Over The Counter (OTC) Drugs Sales Market Share by Type (2016-2026)
Figure 56. Global Over The Counter (OTC) Drugs Revenue Market Share by Type (2016-2026)
Figure 57. Global Over The Counter (OTC) Drugs Price by Type (2016-2026) & (USD/MT)
Figure 58. Global Over The Counter (OTC) Drugs Sales Market Share by Application (2016-2026)
Figure 59. Global Over The Counter (OTC) Drugs Revenue Market Share by Application (2016-2026)
Figure 60. Global Over The Counter (OTC) Drugs Price by Application (2016-2026) & (USD/MT)
Figure 61. North America Over The Counter (OTC) Drugs Sales Market Share by Country (2016-2026)
Figure 62. North America Over The Counter (OTC) Drugs Revenue Market Share by Country (2016-2026)
Figure 63. North America Over The Counter (OTC) Drugs Sales Market Share by Type (2016-2026)
Figure 64. North America Over The Counter (OTC) Drugs Sales Market Share by Application (2016-2026)
Figure 65. Europe Over The Counter (OTC) Drugs Sales Market Share by Country (2016-2026)
Figure 66. Europe Over The Counter (OTC) Drugs Revenue Market Share by Country (2016-2026)
Figure 67. Europe Over The Counter (OTC) Drugs Sales Market Share by Type (2016-2026)
Figure 68. Europe Over The Counter (OTC) Drugs Sales Market Share by Application (2016-2026)
Figure 69. Asia-Pacific Over The Counter (OTC) Drugs Sales Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Over The Counter (OTC) Drugs Revenue Market Share by Region (2016-2026)
Figure 71. Asia-Pacific Over The Counter (OTC) Drugs Sales Market Share by Region (2016-2026)
Figure 72. Asia-Pacific Over The Counter (OTC) Drugs Sales Market Share by Application (2016-2026)
Figure 73. South America Over The Counter (OTC) Drugs Sales Market Share by Country (2016-2026)
Figure 74. South America Over The Counter (OTC) Drugs Revenue Market Share by Country (2016-2026)
Figure 75. South America Over The Counter (OTC) Drugs Sales Market Share by Type (2016-2026)
Figure 76. South America Over The Counter (OTC) Drugs Sales Market Share by Application (2016-2026)
Figure 77. Middle East & Africa Over The Counter (OTC) Drugs Sales Market Share by Country (2016-2026)
Figure 78. Middle East & Africa Over The Counter (OTC) Drugs Revenue Market Share by Country (2016-2026)
Figure 79. Middle East & Africa Over The Counter (OTC) Drugs Sales Market Share by Type (2016-2026)
Figure 80. Middle East & Africa Over The Counter (OTC) Drugs Sales Market Share by Application (2016-2026)
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
店頭販売（OTC）薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription. Scope of the Report: This report focuses on the Over The Counter (OTC) …- 店頭販売（OTC）薬および栄養補助食品の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription. Dietary supplements are products intended to supplement the diet. They …
- 世界の店頭（OTC）医薬品＆栄養補助食品市場 2021：企業別、地域別、種類・用途別 The Over the Counter (OTC) Drugs & Dietary Supplements market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain …
- 市販薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 OTC drugs are medicines that can be bought without a prescription from a doctor. Scope of the Report: This report focuses on the Over-the-Counter Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market bas…
- ダイエット栄養補助食品の世界市場2018-2025 Consumers have started viewing healthy weight as the base of overall well-being. Hence, consumers are seeking products that can help them in weight management.Increase in the demand for weight loss dietary supplements has also tightened the regulations around product safety, manufacturing as well as…